BM
Meyer, Benjamin
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA–peptide conjugates | Proceedings of the National Academy of Sciences of the United States of America | 2025 | 91 | 113 | |||
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | 2024 | 73 | 118 | |||
| SARS-CoV-2 viral load and shedding kinetics | Nature reviews. Microbiology | 2023 | 213 | 118 | |||
| Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus | PloS one | 2023 | 106 | 49 | |||
| SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses | EBioMedicine | 2023 | 114 | 193 | |||
| Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | 2023 | 202 | 49 | |||
| Influence of circadian clocks on adaptive immunity and vaccination responses | Nature communications | 2023 | 313 | 87 | |||
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 170 | 179 | |||
| Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva | Epidemics | 2022 | 194 | 118 | |||
| Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | 2022 | 118 | 88 | |||
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 86 | 0 | |||
| Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | 2022 | 1,451 | 212 | |||
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 444 | 142 | |||
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 157 | 133 | |||
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | 2022 | 284 | 182 | |||
| Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine | 2022 | 279 | 295 | |||
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 198 | 149 | |||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | 2021 | 438 | 224 | |||
| SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 381 | 38 | |||
| Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | 2021 | 437 | 267 | |||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 523 | 320 | |||
| Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | 2021 | 313 | 163 | |||
| Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort study | Infection Control and Hospital Epidemiology | 2021 | 315 | 206 | |||
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | 2021 | 301 | 275 | |||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 406 | 216 | |||
| Waning antibodies to SARS-CoV-2 - Don't panic | The Lancet Regional Health. Europe | 2021 | 174 | 76 | |||
| Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana | One Health Outlook | 2021 | 259 | 126 | |||
| SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | 2021 | 418 | 256 | |||
| A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | 2021 | 348 | 238 | |||
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | 2021 | 645 | 166 | |||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 340 | 196 | |||
| Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT) | Emerging Microbes & Infections | 2020 | 462 | 221 | |||
| Validation of a commercially available SARS-CoV-2 serological immunoassay | Clinical Microbiology and Infection | 2020 | 523 | 315 | |||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet | 2020 | 779 | 14 | |||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 457 | 407 | |||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 379 | 201 | |||
| SARS-CoV-2 seroprevalence in COVID-19 hotspots | The Lancet | 2020 | 351 | 113 | |||
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 520 | 207 | |||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | 2020 | 268 | 109 | |||
| Link of a ubiquitous human coronavirus to dromedary camels | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 229 | 152 |
